Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1989 4
1990 2
1991 5
1992 4
1993 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Sublingual apomorphine and Parkinson's disease.
Lees AJ, Montastruc JL, Turjanski N, Rascol O, Kleedorfer B, Peyro Saint-Paul H, Stern GM, Rascol A. Lees AJ, et al. Among authors: kleedorfer b. J Neurol Neurosurg Psychiatry. 1989 Dec;52(12):1440. doi: 10.1136/jnnp.52.12.1440. J Neurol Neurosurg Psychiatry. 1989. PMID: 2614447 Free PMC article. No abstract available.
Intranasal apomorphine in Parkinson's disease.
Kleedorfer B, Turjanski N, Ryan R, Lees AJ, Milroy C, Stern GM. Kleedorfer B, et al. Neurology. 1991 May;41(5):761-2. doi: 10.1212/wnl.41.5.761-a. Neurology. 1991. PMID: 2027501 No abstract available.
The dopaminergic response in multiple system atrophy.
Hughes AJ, Colosimo C, Kleedorfer B, Daniel SE, Lees AJ. Hughes AJ, et al. Among authors: kleedorfer b. J Neurol Neurosurg Psychiatry. 1992 Nov;55(11):1009-13. doi: 10.1136/jnnp.55.11.1009. J Neurol Neurosurg Psychiatry. 1992. PMID: 1469394 Free PMC article.
Side-effects of subcutaneous apomorphine in Parkinson's disease.
Poewe W, Kleedorfer B, Wagner M, Benke T, Gasser T, Oertel W. Poewe W, et al. Among authors: kleedorfer b. Lancet. 1989 May 13;1(8646):1084-5. doi: 10.1016/s0140-6736(89)92487-2. Lancet. 1989. PMID: 2566037 No abstract available.
Subcutaneous apomorphine in Parkinson's disease.
Poewe W, Kleedorfer B, Gerstenbrand F, Oertel W. Poewe W, et al. Among authors: kleedorfer b. Lancet. 1988 Apr 23;1(8591):943. doi: 10.1016/s0140-6736(88)91755-2. Lancet. 1988. PMID: 2895868 No abstract available.
Treatment of writers' dystonia.
Lees AJ, Kleedorfer B, Foster H. Lees AJ, et al. Among authors: kleedorfer b. Lancet. 1989 Dec 23-30;2(8678-8679):1525. doi: 10.1016/s0140-6736(89)92969-3. Lancet. 1989. PMID: 2574799 No abstract available.
Buspirone in the treatment of levodopa induced dyskinesias.
Kleedorfer B, Lees AJ, Stern GM. Kleedorfer B, et al. J Neurol Neurosurg Psychiatry. 1991 Apr;54(4):376-7. doi: 10.1136/jnnp.54.4.376-a. J Neurol Neurosurg Psychiatry. 1991. PMID: 2056334 Free PMC article. No abstract available.
Intranasal apomorphine: a new treatment in Parkinson's disease.
Kapoor R, Turjanski N, Frankel J, Kleedorfer B, Lees A, Stern G, Bovingdon M, Webster R. Kapoor R, et al. Among authors: kleedorfer b. J Neurol Neurosurg Psychiatry. 1990 Nov;53(11):1015. doi: 10.1136/jnnp.53.11.1015. J Neurol Neurosurg Psychiatry. 1990. PMID: 2283516 Free PMC article. No abstract available.
20 results